Paula Calvert

1.6k total citations
41 papers, 657 citations indexed

About

Paula Calvert is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Paula Calvert has authored 41 papers receiving a total of 657 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Oncology, 13 papers in Pulmonary and Respiratory Medicine and 8 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Paula Calvert's work include Cancer Immunotherapy and Biomarkers (7 papers), Lung Cancer Research Studies (6 papers) and Lung Cancer Treatments and Mutations (5 papers). Paula Calvert is often cited by papers focused on Cancer Immunotherapy and Biomarkers (7 papers), Lung Cancer Research Studies (6 papers) and Lung Cancer Treatments and Mutations (5 papers). Paula Calvert collaborates with scholars based in Ireland, United States and United Kingdom. Paula Calvert's co-authors include Harold Frucht, Thomas C. Hamilton, Kang-Shen Yao, Peter J. O’Dwyer, Ruth Plummer, Hilary Calvert, Alan V. Boddy, Rob Johnson, Martin Griffin and Ashraf Azzabi and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Annals of Internal Medicine.

In The Last Decade

Paula Calvert

39 papers receiving 630 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Paula Calvert Ireland 12 308 195 194 110 87 41 657
Parvin F. Peddi United States 14 404 1.3× 206 1.1× 200 1.0× 57 0.5× 152 1.7× 30 661
A. Bowman United Kingdom 16 354 1.1× 171 0.9× 182 0.9× 111 1.0× 105 1.2× 35 739
S. Matthews United States 14 288 0.9× 276 1.4× 218 1.1× 49 0.4× 43 0.5× 41 747
Mahvish Muzaffar United States 13 348 1.1× 97 0.5× 143 0.7× 57 0.5× 100 1.1× 66 607
Anselmo Papa Italy 12 335 1.1× 313 1.6× 86 0.4× 77 0.7× 160 1.8× 25 675
Domenico Sergi Italy 16 359 1.2× 178 0.9× 166 0.9× 82 0.7× 157 1.8× 54 796
Tze‐Kiong Er Taiwan 17 204 0.7× 390 2.0× 73 0.4× 130 1.2× 123 1.4× 56 838
Tingting Liu China 16 361 1.2× 255 1.3× 169 0.9× 54 0.5× 87 1.0× 77 770
Cristina Pérez-Ramírez Spain 14 211 0.7× 309 1.6× 161 0.8× 156 1.4× 177 2.0× 50 762
Pilar Zamora Spain 17 303 1.0× 270 1.4× 195 1.0× 110 1.0× 202 2.3× 55 795

Countries citing papers authored by Paula Calvert

Since Specialization
Citations

This map shows the geographic impact of Paula Calvert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paula Calvert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paula Calvert more than expected).

Fields of papers citing papers by Paula Calvert

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paula Calvert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paula Calvert. The network helps show where Paula Calvert may publish in the future.

Co-authorship network of co-authors of Paula Calvert

This figure shows the co-authorship network connecting the top 25 collaborators of Paula Calvert. A scholar is included among the top collaborators of Paula Calvert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paula Calvert. Paula Calvert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Elhassan, Mohamed, et al.. (2024). Unusual Presentation of Non-Gestational Extragonadal Choriocarcinoma. Cureus. 16(11). e74072–e74072. 1 indexed citations
2.
Clarke, Rachel, et al.. (2023). Case Series: Cemiplimab and Nivolumab Immunotherapy as Promising Treatment in Advanced or Metastatic Cutaneous Squamous Cell Carcinoma. SHILAP Revista de lepidopterología. 16(1). 1156–1165. 1 indexed citations
3.
Jordan, Emmet, et al.. (2023). Systemic anti-cancer therapy in older patients with gastrointestinal malignancies following comprehensive geriatric assessment: An age-based subgroup analysis.. Journal of Clinical Oncology. 41(4_suppl). 796–796. 1 indexed citations
4.
Mullally, William, Fiachra Cooke, V. E. Abernethy, et al.. (2022). Case Report: Thrombotic-Thrombocytopenic Purpura Following Ipilimumab and Nivolumab Combination Immunotherapy for Metastatic Melanoma. Frontiers in Immunology. 13. 871217–871217. 9 indexed citations
5.
Mullally, William, John Greene, Emmet Jordan, et al.. (2022). The prognostic value of the derived neutrophil-to-lymphocyte ratio (dNLR) in patients treated with immune checkpoint inhibitors. Irish Journal of Medical Science (1971 -). 192(1). 83–87. 4 indexed citations
6.
Ahmed, Yasar, et al.. (2021). Colonic Metastasis of Primary Lung Cancer. Case Reports in Oncology. 14(2). 901–905. 2 indexed citations
7.
Hennessy, Martina, et al.. (2021). 1619P Transition to a virtual cancer multidisciplinary team meeting during the COVID-19 pandemic: Experience from a regional Irish Cancer Centre. Annals of Oncology. 32. S1152–S1152. 1 indexed citations
8.
Greene, John, William Mullally, Yasar Ahmed, et al.. (2020). Maintaining a Medical Oncology Service during the Covid-19 Pandemic.. PubMed. 113(5). 77–77. 1 indexed citations
9.
O’Leary, Connor, et al.. (2019). Professional burnout, work patterns and career satisfaction in medical oncologists in Ireland. Irish Journal of Medical Science (1971 -). 189(2). 711–718. 7 indexed citations
10.
11.
Ahmed, Yasar, et al.. (2019). EP1.01-47 Thyroid Related Adverse Events Predict Survival in NSCLC Patients Receiving Anti-PD-1/ PD-L1 Therapy. Journal of Thoracic Oncology. 14(10). S930–S930. 3 indexed citations
12.
O’Leary, Connor, et al.. (2018). Epidermal growth factor receptor mutated oligometastatic adeno-squamous lung cancer transformation to small cell lung cancer. Oxford Medical Case Reports. 2018(10). omy078–omy078. 2 indexed citations
13.
Keegan, Niamh M., et al.. (2016). Comparing attitudes of younger and older patients towards cancer clinical trials. Journal of Geriatric Oncology. 7(3). 162–168. 19 indexed citations
14.
Floquet, Anne, Ignace Vergote, Nicoletta Colombo, et al.. (2014). Progression-free survival by local investigator versus independent central review: Comparative analysis of the AGO-OVAR16 Trial. Gynecologic Oncology. 136(1). 37–42. 22 indexed citations
15.
Naidoo, Jarushka, et al.. (2013). Prophylactic cranial irradiation in small cell lung cancer: a single institution experience. Irish Journal of Medical Science (1971 -). 183(1). 129–132. 4 indexed citations
16.
Naidoo, Jarushka, Min Yuen Teo, Sandra Deady, Harry Comber, & Paula Calvert. (2013). Should Patients with Extrapulmonary Small-Cell Carcinoma Receive Prophylactic Cranial Irradiation?. Journal of Thoracic Oncology. 8(9). 1215–1221. 31 indexed citations
17.
Vergote, Ignace, Éric Pujade-Lauraine, Sandro Pignata, et al.. (2010). European Network of Gynaecological Oncological Trial Groups’ Requirements for Trials Between Academic Groups and Pharmaceutical Companies. International Journal of Gynecological Cancer. 20(3). 476–478. 13 indexed citations
18.
Coffey, John Calvin, et al.. (2007). Life-threatening gastrointestinal haemorrhage in Von Recklinghausen's disease. The Surgeon. 5(3). 186–189. 3 indexed citations
19.
Calvert, Paula, Alan V. Boddy, Martin J. Griffin, et al.. (2002). Topotecan in combination with carboplatin: phase I trial evaluation of two treatment schedules. Annals of Oncology. 13(3). 399–402. 9 indexed citations
20.
Calvert, Paula, Kang-Shen Yao, Thomas C. Hamilton, & Peter J. O’Dwyer. (1998). Clinical studies of reversal of drug resistance based on glutathione. Chemico-Biological Interactions. 111-112. 213–224. 98 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Parvin F. Peddi Breakdown of academic impact, for papers by A. Bowman Breakdown of academic impact, for papers by S. Matthews Breakdown of academic impact, for papers by Mahvish Muzaffar Breakdown of academic impact, for papers by Anselmo Papa Breakdown of academic impact, for papers by Domenico Sergi Breakdown of academic impact, for papers by Tze‐Kiong Er Breakdown of academic impact, for papers by Tingting Liu Breakdown of academic impact, for papers by Cristina Pérez-Ramírez Breakdown of academic impact, for papers by Pilar Zamora
Rankless by CCL
2026